2026 POSTER PRESENTATIONS
P01: A Melt-Curve-Free Seven-Target Respiratory Multiplex with Cross-Platform Reproducibility Using Thermo-Induced Switching Probes (TISP), Presented by JungKwon Y. & Jaehyeon L., Amplidea Co., Ltd.
P02: Bridge LAB, POC, PON and At-Home Multianalyte IVD with a Single, Simple-to-Use Method and Platform Technology, Presented by Andrew D., BioMEMS Diagnostics, Inc.
P03: Canine Olfaction Combined with Bayesian Modeling for Multicancer Detection from Breath Samples: A Phase II Study in India, Presented by Amir A., Dognosis
P04: Development and Comparison of Vision Transformers for Detection of Blood Smears with Plasmodium falciparum, Presented by Paul N., George Washington University
P05: Beyond Genomic Scarring: dSTRIDE-HR and sSTRIDE-RS for Real-Time, Single-Cell DDR Pathway Assessment, Presented by Maggie RC., intoDNA
P06: Bloodstream Infection Pathogen and AMR Identification in 3 Hours Directly from Blood: Single Cell Precision of Digital PCR, Presented by Mridu S., MelioLabs
P07: Clinically-Relevant Respiratory Pathogen Detection in Polymicrobial Samples by Targeted Next-Generation Sequencing, Presented by Sharon KD., National Jewish Health
P08: A Ternary, Low-Affinity NanoLuc® Luciferase-Based Homogeneous Immunoassay Platform for Rapid Detection of Pathogens, Presented by Marty E., Promega Corporation
P09: Enhancing PCR Sensitivity Through Live-Dead Discrimination of Viral Pathogens, Presented by Malik K., Promega Corporation
P10: Maxwell® Rapid ccfDNA Kit: Enhancing Circulating Cell-Free DNA Extraction, Presented by Ruchika S., Promega Corporation
P11: Maxwell® XtractAll FFPE DNA/RNA Kit: A Versatile Chemistry for Extraction of DNA and RNA Sequentially, Total Nucleic Acid, DNA, or RNA from FFPE Tissues, Presented by Alok S., Promega Corporation
P12: Macrophage-Derived Exosomal miR-222 and DCUN1D1 Expression Under Hypoxia for Aggressiveness in Canine Mammary Tumor Cells, Presented by Yongbaek K., Seoul National University
P13: We Do Not Have an Innovation Problem: Alignment Failure in Digital Pathology, Presented by Esther A., SolarisRTC
P14: CA-62 and Combined Biomarker Performance in Pulmonary Lesions: A Prospective Confirmation, Presented by Evgueni K., UCM Technologies, Inc.
P15: Rapid Concentration of Urinary EV-Associated Particles for Liquid Biopsy Workflows, Presented by David A., Vytas Bio LLC
P16: Development of a High-Sensitivity Diagnostic Platform for Enhanced Detection of Highly Pathogenic Avian Influenza H5 Clade 2.3.4.4b, Presented by Hyun P., Wonkwang University